SCM
FBIO icon

Segantii Capital Management’s Fortress Biotech FBIO Stock Holding History

Segantii Capital Management’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-2,520
Closed -$113K – 53
2016
Q1 		$113K Buy
+2,520
New +$106K 0.05% 133

Other funds holding FBIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
EM
Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BGA
Belmont Global Advisors Dallas, Texas $106M AUM 2.89% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Segantii Capital Management's FBIO Position: Q2 2016 in Review

Segantii Capital Management sold out of Fortress Biotech (FBIO) in Q2 2016, closing a stake of 2,520 shares — an estimated $113K sold.

Segantii Capital Management first reported a position in FBIO in Q1 2016 and held it in 1 quarter. The position peaked at $113K in Q1 2016. 52 funds tracked by Wall St. Rank hold FBIO as of Q2 2016.

  • Segantii Capital Management reported no remaining Fortress Biotech position as of Q2 2016 after selling out during the quarter.
  • Segantii Capital Management sold 2,520 Fortress Biotech shares in Q2 2016, an estimated $113K.
  • Segantii Capital Management first reported a position in Fortress Biotech in Q1 2016 and held it in 1 quarter.
  • Segantii Capital Management's Fortress Biotech position peaked at $113K in Q1 2016.
  • 52 funds tracked by Wall St. Rank held Fortress Biotech as of Q2 2016.

Based on Segantii Capital Management's 13F filing for Q2 2016, filed 15 Aug 2016.